TMOD Stock Overview
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Thermo Fisher Scientific Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$27.00 |
| 52 Week High | US$27.00 |
| 52 Week Low | US$27.00 |
| Beta | 0.77 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| TMOD | AR Life Sciences | AR Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how TMOD performed against the AR Life Sciences industry.
Return vs Market: Insufficient data to determine how TMOD performed against the AR Market.
Price Volatility
| TMOD volatility | |
|---|---|
| TMOD Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in AR Market | 0% |
| 10% least volatile stocks in AR Market | 0% |
Stable Share Price: TMOD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TMOD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 130,000 | Marc Casper | www.thermofisher.com |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
Thermo Fisher Scientific Inc. Fundamentals Summary
| TMOD fundamental statistics | |
|---|---|
| Market cap | US$200.29b |
| Earnings (TTM) | US$6.02b |
| Revenue (TTM) | US$43.81b |
33.2x
P/E Ratio4.6x
P/S RatioIs TMOD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMOD income statement (TTM) | |
|---|---|
| Revenue | US$43.81b |
| Cost of Revenue | US$26.10b |
| Gross Profit | US$17.71b |
| Other Expenses | US$11.68b |
| Earnings | US$6.02b |
Last Reported Earnings
Apr 01, 2023
Next Earnings Date
Jul 26, 2023
| Earnings per share (EPS) | 15.62 |
| Gross Margin | 40.42% |
| Net Profit Margin | 13.75% |
| Debt/Equity Ratio | 82.8% |
How did TMOD perform over the long term?
See historical performance and comparison